Safety of blood products derived from plasma pools: the positive impact of anti-HCV screening on the quality of such products

Vox Sang. 1996;71(3):184-6. doi: 10.1046/j.1423-0410.1996.7130184.x.
No abstract available

MeSH terms

  • Blood Component Transfusion* / adverse effects
  • Blood Transfusion*
  • Hepatitis C / prevention & control*
  • Hepatitis C Antigens / blood*
  • Humans
  • Immunoglobulins / chemistry
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Safety
  • Transfusion Reaction

Substances

  • Hepatitis C Antigens
  • Immunoglobulins